Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib in Advanced/Metastatic Breast Cancer
NCT00109265Phase 2Completed
- Sponsor
- Genentech
- Start
- May 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of erlotinib in breast cancer, sponsored by Genentech. Started May 2001; status: completed.
02
Drugs
erlotinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00109265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109265.